Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults

Lactobacillus johnsonii N6.2 mitigates the onset of type 1 diabetes (T1D) in biobreeding diabetes-prone rats, in part, through changes in kynurenine:tryptophan (K:T) ratios. The goal of this pilot study was to determine the safety, tolerance, and general immunological response of L. johnsonii N6.2 i...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Guillermo E. Marcial, Amanda L. Ford, Michael J. Haller, Salvador A. Gezan, Natalie A. Harrison, Dan Cai, Julie L. Meyer, Daniel J. Perry, Mark A. Atkinson, Clive H. Wasserfall, Timothy Garrett, Claudio F. Gonzalez, Todd M. Brusko, Wendy J. Dahl, Graciela L. Lorca
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2017-06-01
Colecção:	Frontiers in Immunology
Assuntos:	Lactobacillus johnsonii diabetes type I probiotic indoleamine-2,3-dioxygenase microbiome gastrointestinal symptom
Acesso em linha:	http://journal.frontiersin.org/article/10.3389/fimmu.2017.00655/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!